Gouvernance Agenus Inc.

AGEN

US00847G8042

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 24/09/2026			Varia. 5j.	Varia. 1 janv.
8,500 ^USD	+1,19%		+17,73%	+170,70%

18/09	Agenus Inc. : Opinion positive de Chardan Research	ZM
11/09	Transcript : Agenus Inc. - Shareholder/Analyst Call

Comité Exécutif: Agenus Inc.

Dirigeant

Fonctions occupéesDepuis

Garo Armen

73 ans

Chief Executive Officer	31/03/1994
Director of Finance/CFO	08/01/2026
Founder	31/03/1994

Zachary Armen

Investor Relations Contact

01/12/2022

Steven O’Day

65 ans

Chief Tech/Sci/R&D Officer

01/01/2021

Tracy Mazza Clemente

Human Resources Officer

01/03/2019

Craig Winter

Chief Tech/Sci/R&D Officer

01/11/2021

Kamel Djazouli

Chief Tech/Sci/R&D Officer

Composition du Conseil d'Administration: Agenus Inc.

Administrateur

ComitésDepuis

Garo Armen

73 ans

Executive Committee

04/11/2010

Brian Corvese

68 ans

Governance Committee	01/07/2017
Nominating Committee	01/07/2017
Executive Committee Chair	08/03/2007
Compensation Committee Chair
Compensation Committee	28/07/2017
Audit Committee Chair	28/07/2017
Audit Committee	01/07/2017

Thomas Harrison

78 ans

Audit Committee	24/06/2021
Compensation Committee Chair	01/07/2020
Compensation Committee	24/06/2021
Audit Committee Chair	05/11/2024
Finance Committee Chair	05/11/2024
Governance Committee Chair	05/11/2024
Nominating Committee Chair	05/11/2024

Timothy Wright

68 ans

Audit Committee	18/07/2025
Finance Committee	14/06/2012
Executive Committee	07/12/2006
Compensation Committee
Governance Committee Chair	18/07/2025
Nominating Committee Chair	18/07/2025

Susan Hirsch

73 ans

Audit Committee	25/09/2023
Finance Committee
Compensation Committee
Governance Committee	25/09/2023
Nominating Committee	25/09/2023

Marco Tullio Marcucci

55 ans

Governance Committee	05/08/2026
Nominating Committee	05/08/2026

Jennifer Buell

52 ans

Director/Board Member

11/06/2024

Dernières Nominations: Agenus Inc.

11/08	Agenus Inc. annonce la nomination de Marco Tullio Marcucci en tant qu'administrateur et membre du comité de gouvernance d'entreprise et des nominations, à compter du 5 août 2026	CI
15/05	Agenus Inc. annonce la démission d'Austin Charette, responsable de la comptabilité, effective au 29 mai 2026	CI
28/04	Biodlink International Company Limited annonce des changements au sein de sa direction et de ses comités, effectifs au 29 avril 2026	CI
19/03	MiNK Therapeutics, Inc. nomme Austin Charette au poste de responsable de la comptabilité, à compter du 13 mars 2026	CI
14/01	Agenus Inc. nomme Austin Charette au poste de Principal Accounting Officer à compter du 8 janvier 2026	CI
18/11	Agenus Inc. nomme le Dr José Iglesias au poste de Chief Medical Affairs Officer, à compter du 10 novembre 2025	CI
12/05/25	Richard Goldberg rejoint Agenus Inc. en tant que directeur du développement	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Agenus Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Christine Klaskin

Comptroller/Controller/Auditor	21/06/2012	08/01/2026
Director of Finance/CFO	01/10/2006	08/01/2026
Corporate Officer/Principal	01/01/1996	01/10/2006

Ulf Arne Wiinberg

Director/Board Member	17/05/2016	05/11/2024
Independent Dir/Board Member	17/05/2016	05/11/2024

Allison Jeynes-Ellis

Director/Board Member	07/11/2018	11/06/2024
Independent Dir/Board Member	07/11/2018	11/06/2024

Julie DeSander

Corporate Officer/Principal

01/12/2023

Wadih Jordan

Director/Board Member	01/03/2003	31/12/2022
Independent Dir/Board Member	01/03/2003	31/12/2022

Andy Hurley

Chief Tech/Sci/R&D Officer	01/11/2021	01/07/2022
Corporate Officer/Principal	09/02/2021	01/11/2021

Paulo Moreira

Corporate Officer/Principal

21/03/2019

01/12/2021

Jan Medina

Investor Relations Contact

01/02/2021

01/10/2021

Adam F. Krauss

Compliance Officer	01/11/2020	30/07/2021
General Counsel	01/11/2020	30/07/2021

Donald Vidic

Corporate Officer/Principal

18/07/2019

01/07/2021

Paul Clark

Director/Board Member	27/08/2020	15/06/2021
Independent Dir/Board Member	27/08/2020	15/06/2021

Evan Kearns

General Counsel	01/01/2014	30/04/2021
Corporate Secretary	12/07/2018	30/04/2021

Ozer Baysal

Human Resources Officer	01/07/2017	01/04/2019
Corporate Officer/Principal	01/05/2019	01/04/2020

Alexander Duncan

Chief Tech/Sci/R&D Officer

01/01/2015

02/01/2020

Christian Cortis

Director of Finance/CFO	12/07/2018	14/08/2019
Corporate Officer/Principal	01/01/2015	12/07/2018

Michael Plater

Corporate Officer/Principal

01/05/2017

01/10/2018

Sunil Gupta

General Counsel

16/07/2018

Anna Wijatyk

Chief Tech/Sci/R&D Officer

16/07/2018

Karen Valentine

Compliance Officer	01/01/2004	12/07/2018
General Counsel	01/01/2004	12/07/2018
Corporate Secretary	01/01/2004	12/07/2018

Shalini Sharp

Director/Board Member	01/01/2012	20/06/2018
Director of Finance/CFO	01/08/2003	01/01/2012
Independent Dir/Board Member	01/01/2012	20/06/2018
Investor Relations Contact	01/04/2010	01/01/2012

Jean-Marie Cuillerot

Chief Tech/Sci/R&D Officer	30/01/2017	17/01/2018
Corporate Officer/Principal	28/07/2016	30/01/2017

Marc van Dijk

Chief Tech/Sci/R&D Officer

01/03/2020

Mohammed Malik

Director/Board Member	01/03/2014	28/06/2017
Independent Dir/Board Member	01/05/2015	28/06/2017

James Gorman

Corporate Officer/Principal

18/10/2016

Justin Zelin

Corporate Officer/Principal

01/09/2015

01/09/2016

Charles Ballantyne

Director of Finance/CFO

17/06/2015

29/07/2016

Alfred Dadson

Corporate Officer/Principal

01/01/2016

Tom Dechaene

Director/Board Member	01/01/1999	31/12/2015
Independent Dir/Board Member	01/01/1999	31/12/2015

Ernest Shingyan Wong

Corporate Officer/Principal

01/05/2015

01/12/2015

Kerry Wentworth

Chief Tech/Sci/R&D Officer	01/01/2005	10/07/2014
General Counsel	01/01/2005	10/07/2014

Timothy Rothwell

Director/Board Member	16/06/2009	08/12/2011
Independent Dir/Board Member	15/06/2009	08/12/2011

John Hatsopoulos

Director/Board Member	01/04/2010	08/12/2011
Independent Dir/Board Member	01/01/2007	08/12/2011

Hyam Levitsky

Director/Board Member

13/09/2006

28/08/2011

Jonae Barnes

Investor Relations Contact

01/01/2011

Margaret Eisen

Director/Board Member

01/03/2003

10/06/2009

Deanna Petersen

Corporate Officer/Principal

01/04/2002

01/03/2009

Roman Chicz

Chief Tech/Sci/R&D Officer

01/07/2004

18/05/2007

Noubar Afeyan

Director/Board Member

01/01/1998

Bruce Leicher

General Counsel	01/12/2006	01/12/2006
Corporate Secretary	01/12/2006	01/12/2006

Mark Kessel

Director/Board Member

01/03/2003

14/09/2006

Alastair J. J. Wood

Director/Board Member

14/09/2006

Peter Thornton

Director of Finance/CFO

01/06/2004

01/09/2006

Renu Gupta

Corporate Officer/Principal

01/08/2006

Gamil de Chadarevian

Director/Board Member

01/01/1995

14/06/2006

Russell Herndon

Chief Operating Officer	01/11/2003	01/12/2005
President	01/11/2000	01/12/2005

Axel Hoos

Corporate Officer/Principal

01/01/2001

01/01/2005

Wei Wu

Corporate Officer/Principal

01/01/2005

Michael Aberman

Corporate Officer/Principal

01/03/2004

Neal Gordon

Corporate Officer/Principal

01/01/2004

Jonathan Lewis

Chairman	01/06/2000	01/11/2003
Chief Tech/Sci/R&D Officer	01/06/2000	01/11/2003

Martin Taylor

Director/Board Member

01/01/1999

01/01/2003

John Cerio

Chief Administrative Officer	01/01/2003	-
Human Resources Officer	01/01/2003	-

Robert P. Gale

Chief Tech/Sci/R&D Officer

01/04/2001

01/05/2002

Andreas Woppmann

Corporate Officer/Principal

01/01/2002

Pramod Srivastava

Director/Board Member	31/03/1994	-
Founder	31/03/1994	-

Michelle Linn

Public Communications Contact

Charles Richter King

Director/Board Member

Renu Vijaya

Corporate Officer/Principal

Pierre Champagne

Chief Tech/Sci/R&D Officer

Regina Grebla

Investor Relations Contact	-	-
Public Communications Contact	-	-

Paul H. Fischer

Chief Tech/Sci/R&D Officer

Jeffrey Rona

Director of Finance/CFO

Ashkan Afkhami

Corporate Officer/Principal

Robert Anstey

Public Communications Contact

Alem Truneh

Chief Tech/Sci/R&D Officer

James Zabrecky

Corporate Officer/Principal

Jeff Clark

Director of Finance/CFO

Marcel Rozencweig

Chief Tech/Sci/R&D Officer

Janice McCourt

Corporate Officer/Principal

Samuel D. Waksal

Director/Board Member

Jason E. Moore

Corporate Officer/Principal

Robert Stein

Chief Tech/Sci/R&D Officer

13/01/2014

01/04/2017

Frank AtLee

Director/Board Member

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	11
Femme	4

Dont comité exécutif

Homme	5
Femme	1

Dont Administrateurs

Homme	6
Femme	1

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Agenus Inc. est une société spécialisée en immuno-oncologie (I-O) qui lutte contre le cancer grâce à un vaste portefeuille de produits immunologiques. La société s’attache à élargir les populations de patients pouvant bénéficier de l’immunothérapie anticancéreuse par le biais d’approches combinées, en s’appuyant sur un large éventail de traitements par anticorps, de thérapies cellulaires adoptives (par l’intermédiaire de MiNK Therapeutics) et d’adjuvants. Son portefeuille I-O s'appuie sur plusieurs plateformes et programmes, notamment diverses plateformes de découverte d'anticorps, des programmes de candidats-anticorps, sa plateforme d'adjuvants vaccinaux à base de saponine, ainsi qu'un pipeline de nouvelles thérapies allogéniques à base de cellules T tueuses naturelles invariantes (iNKT) destinées au traitement du cancer et d'autres maladies à médiation immunitaire, géré par MiNK. La société a décroché une capacité de production engagée pour répondre aux besoins d'approvisionnement en BOT+BAL destinés à ses essais cliniques, à ses programmes d'accès mondial et à sa future commercialisation.

Employés

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société